Symbols / SUPN Stock Supernus Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
SUPN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 2.90B Enterprise Value — Income — Sales — Book/sh — Cash/sh —
Dividend Yield — Payout — Employees — IPO — P/E — Forward P/E —
PEG — P/S — P/B — P/C — EV/EBITDA — EV/Sales —
Quick Ratio — Current Ratio — Debt/Eq — LT Debt/Eq — EPS (ttm) — EPS next Y —
EPS Growth — Revenue Growth — Earnings — ROA — ROE — ROIC —
Gross Margin — Oper. Margin — Profit Margin — Shs Outstand — Shs Float — Short Float —
Short Ratio — Short Interest — 52W High — 52W Low — Beta — Avg Volume —
Volume — Target Price — Recom — Prev Close — Price — Change —
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest SUPN news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
718.95
+8.63%
661.82
+8.94%
607.52
-8.95%
667.24
Operating Revenue
718.95
+8.63%
661.82
+8.94%
607.52
-8.95%
667.24
Cost Of Revenue
74.56
-4.29%
77.91
-7.01%
83.78
-3.95%
87.22
Reconciled Cost Of Revenue
72.45
-3.99%
75.47
-7.18%
81.31
-3.56%
84.31
Gross Profit
644.39
+10.36%
583.91
+11.49%
523.74
-9.70%
580.02
Operating Expense
681.25
+34.01%
508.36
-0.39%
510.34
-4.50%
534.40
Research And Development
106.23
-2.35%
108.80
+18.78%
91.59
+22.86%
74.55
Selling General And Administration
485.56
+50.99%
321.58
-4.39%
336.36
-10.83%
377.22
Selling And Marketing Expense
288.65
+27.00%
227.29
-0.83%
229.19
-14.42%
267.79
General And Administrative Expense
196.91
+108.84%
94.29
-12.02%
107.17
-2.06%
109.43
Other Gand A
196.91
+108.84%
94.29
-12.02%
107.17
-2.06%
109.43
Total Expenses
755.82
+28.92%
586.26
-1.32%
594.12
-4.42%
621.62
Operating Income
-36.86
-148.79%
75.56
+463.72%
13.40
-70.62%
45.61
Total Operating Income As Reported
-62.28
-176.27%
81.67
+1649.93%
-5.27
-111.42%
46.12
EBITDA
42.53
-76.14%
178.28
+98.00%
90.04
-41.28%
153.36
Normalized EBITDA
67.95
-60.53%
172.17
+58.37%
108.72
-28.87%
152.85
Reconciled Depreciation
91.56
+13.86%
80.41
-5.24%
84.86
-0.80%
85.54
EBIT
-49.03
-150.10%
97.87
+1787.92%
5.18
-92.36%
67.81
Total Unusual Items
-25.42
-516.02%
6.11
+132.72%
-18.67
-3761.18%
0.51
Total Unusual Items Excluding Goodwill
-25.42
-516.02%
6.11
+132.72%
-18.67
-3761.18%
0.51
Special Income Charges
-25.42
-516.02%
6.11
+132.72%
-18.67
-3761.18%
0.51
Impairment Of Capital Assets
0.00
0.00
-100.00%
20.19
0.00
Restructuring And Mergern Acquisition
25.42
+516.02%
-6.11
-302.77%
-1.52
-197.45%
-0.51
Net Income
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Pretax Income
-49.03
-150.10%
97.87
+3434.49%
2.77
-95.44%
60.74
Net Non Operating Interest Income Expense
13.25
-18.21%
16.20
+101.59%
8.04
-45.02%
14.62
Interest Expense Non Operating
0.00
0.00
-100.00%
2.42
-65.84%
7.07
Net Interest Income
13.25
-18.21%
16.20
+101.59%
8.04
-45.02%
14.62
Interest Expense
0.00
0.00
-100.00%
2.42
-65.84%
7.07
Interest Income Non Operating
13.25
-18.21%
16.20
+55.02%
10.45
-51.81%
21.69
Interest Income
13.25
-18.21%
16.20
+55.02%
10.45
-51.81%
21.69
Other Income Expense
-25.42
-516.02%
6.11
+132.72%
-18.67
-3761.18%
0.51
Tax Provision
-10.48
-143.66%
24.00
+1552.10%
1.45
+4440.63%
0.03
Tax Rate For Calcs
0.00
-14.40%
0.00
+19.05%
0.00
+39748.20%
0.00
Tax Effect Of Unusual Items
-5.44
-456.12%
1.53
+138.96%
-3.92
-1459539.90%
0.00
Net Income Including Noncontrolling Interests
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Net Income From Continuing Operation Net Minority Interest
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Net Income From Continuing And Discontinued Operation
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Net Income Continuous Operations
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Normalized Income
-18.57
-126.80%
69.28
+331.21%
16.07
-73.31%
60.20
Net Income Common Stockholders
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Diluted EPS
-0.68
-151.52%
1.32
+6500.00%
0.02
-98.08%
1.04
Basic EPS
-0.68
-150.75%
1.34
+6600.00%
0.02
-98.23%
1.13
Basic Average Shares
56.45
+2.45%
55.10
+1.03%
54.54
+1.62%
53.67
Diluted Average Shares
56.45
+0.88%
55.96
+0.81%
55.51
-10.01%
61.68
Diluted NI Availto Com Stockholders
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.95%
64.27
Average Dilution Earnings
—
0.00
0.00
-100.00%
3.56
Amortization
89.46
+14.72%
77.98
-5.35%
82.39
-0.30%
82.63
Amortization Of Intangibles Income Statement
89.46
+14.72%
77.98
-5.35%
82.39
-0.30%
82.63
Depreciation Amortization Depletion Income Statement
89.46
+14.72%
77.98
-5.35%
82.39
-0.30%
82.63
Depreciation And Amortization In Income Statement
89.46
+14.72%
77.98
-5.35%
82.39
-0.30%
82.63
Line Item Trend 2023-12-31
Total Assets
1,277.67
Current Assets
493.11
Cash Cash Equivalents And Short Term Investments
254.87
Cash And Cash Equivalents
75.05
Cash Equivalents
39.10
Cash Financial
35.96
Other Short Term Investments
179.82
Receivables
144.16
Accounts Receivable
144.16
Gross Accounts Receivable
154.85
Allowance For Doubtful Accounts Receivable
-10.70
Inventory
77.41
Raw Materials
16.27
Work In Process
31.21
Finished Goods
29.92
Prepaid Assets
—
Other Current Assets
16.68
Total Non Current Assets
784.56
Net PPE
13.53
Gross PPE
28.93
Accumulated Depreciation
-15.40
Properties
0.00
Machinery Furniture Equipment
14.91
Construction In Progress
0.00
Other Properties
—
Leases
14.02
Goodwill And Other Intangible Assets
716.91
Goodwill
117.02
Other Intangible Assets
599.89
Investments And Advances
16.62
Non Current Deferred Assets
—
Non Current Deferred Taxes Assets
—
Other Non Current Assets
37.51
Total Liabilities Net Minority Interest
356.16
Current Liabilities
290.20
Payables And Accrued Expenses
204.79
Payables
1.96
Accounts Payable
1.96
Current Accrued Expenses
202.83
Pensionand Other Post Retirement Benefit Plans Current
20.72
Current Debt And Capital Lease Obligation
8.33
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
8.33
Other Current Liabilities
56.35
Total Non Current Liabilities Net Minority Interest
65.96
Long Term Debt And Capital Lease Obligation
33.20
Long Term Debt
—
Long Term Capital Lease Obligation
33.20
Non Current Deferred Liabilities
24.96
Non Current Deferred Taxes Liabilities
24.96
Other Non Current Liabilities
7.80
Stockholders Equity
921.52
Common Stock Equity
921.52
Capital Stock
0.06
Common Stock
0.06
Share Issued
54.72
Ordinary Shares Number
54.72
Treasury Shares Number
0.00
Additional Paid In Capital
439.49
Retained Earnings
482.56
Gains Losses Not Affecting Retained Earnings
-0.59
Other Equity Adjustments
-0.59
Total Equity Gross Minority Interest
921.52
Total Capitalization
921.52
Working Capital
202.92
Invested Capital
921.52
Total Debt
41.53
Net Debt
—
Capital Lease Obligations
41.53
Net Tangible Assets
204.61
Tangible Book Value
204.61
Available For Sale Securities
16.62
Investmentin Financial Assets
16.62
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
47.33
-72.47%
171.95
+54.79%
111.08
-4.91%
116.83
Cash Flow From Continuing Operating Activities
47.33
-72.47%
171.95
+54.79%
111.08
-4.91%
116.83
Net Income From Continuing Operations
-38.55
-152.19%
73.86
+5512.84%
1.32
-97.83%
60.71
Depreciation Amortization Depletion
91.56
+13.86%
80.41
-5.24%
84.86
-0.80%
85.54
Depreciation And Amortization
91.56
+13.86%
80.41
-5.24%
84.86
-0.80%
85.54
Other Non Cash Items
30.38
+2047.28%
1.42
-71.19%
4.91
+140.30%
-12.19
Stock Based Compensation
33.05
+19.08%
27.75
+3.72%
26.76
+52.32%
17.57
Asset Impairment Charge
1.93
-78.30%
8.88
-68.54%
28.21
+170.18%
10.44
Deferred Tax
5.21
+125.85%
-20.14
+21.69%
-25.71
+2.32%
-26.32
Deferred Income Tax
5.21
+125.85%
-20.14
+21.69%
-25.71
+2.32%
-26.32
Operating Gains Losses
0.44
+4977.78%
-0.01
—
-0.01
Gain Loss On Investment Securities
0.44
+4977.78%
-0.01
—
-0.01
Change In Working Capital
-75.16
-3562.72%
-2.05
+77.54%
-9.14
+58.74%
-22.14
Change In Receivables
-22.30
-1173.34%
2.08
-88.93%
18.77
+214.66%
-16.37
Changes In Account Receivables
-22.30
-1173.34%
2.08
-88.93%
18.77
+214.66%
-16.37
Change In Inventory
-7.50
-147.46%
15.81
+158.69%
6.11
+134.21%
-17.86
Change In Prepaid Assets
-13.18
+31.90%
-19.35
-5694.01%
-0.33
-102.71%
12.30
Change In Payables And Accrued Expense
-32.17
-5409.25%
-0.58
+98.27%
-33.68
-15070.27%
-0.22
Change In Accrued Expense
-7.61
-152.72%
14.43
+453.12%
2.61
-86.23%
18.94
Change In Payable
-24.57
-63.61%
-15.02
+58.62%
-36.29
-89.36%
-19.16
Change In Account Payable
-24.57
-63.61%
-15.02
+58.62%
-36.29
-89.36%
-19.16
Change In Other Current Liabilities
—
—
0.00
+100.00%
-2.10
Investing Cash Flow
4.11
+102.16%
-189.87
-170.65%
268.73
+224.03%
-216.66
Cash Flow From Continuing Investing Activities
4.11
+102.16%
-189.87
-170.65%
268.73
+224.03%
-216.66
Net PPE Purchase And Sale
-1.34
-84.55%
-0.72
-31.58%
-0.55
-33.74%
-0.41
Purchase Of PPE
-1.34
-84.55%
-0.72
-31.58%
-0.55
-33.74%
-0.41
Capital Expenditure
-1.34
-84.55%
-0.72
-31.58%
-0.55
-33.74%
-0.41
Net Investment Purchase And Sale
298.54
+257.84%
-189.14
-170.24%
269.28
+224.52%
-216.25
Purchase Of Investment
-475.94
+30.82%
-688.01
-577.04%
-101.62
+75.03%
-406.99
Sale Of Investment
774.48
+55.25%
498.87
+34.50%
370.90
+94.45%
190.74
Net Business Purchase And Sale
-293.09
0.00
0.00
0.00
Purchase Of Business
-293.09
0.00
0.00
0.00
Financing Cash Flow
9.13
-25.12%
12.19
+103.06%
-397.88
-3697.65%
-10.48
Cash Flow From Continuing Financing Activities
9.13
-25.12%
12.19
+103.06%
-397.88
-3697.65%
-10.48
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-402.50
0.00
Issuance Of Debt
0.00
0.00
-100.00%
93.00
0.00
Repayment Of Debt
0.00
0.00
+100.00%
-495.50
0.00
Long Term Debt Issuance
0.00
0.00
-100.00%
93.00
0.00
Long Term Debt Payments
0.00
0.00
+100.00%
-495.50
0.00
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-402.50
0.00
Short Term Debt Issuance
—
—
93.00
0.00
Short Term Debt Payments
—
—
-402.50
0.00
Net Short Term Debt Issuance
—
—
-402.50
0.00
Net Common Stock Issuance
37.62
+152.32%
14.91
+125.54%
6.61
-46.79%
12.42
Net Other Financing Charges
-28.49
-949.21%
-2.71
-36.43%
-1.99
+91.31%
-22.90
Changes In Cash
60.57
+1158.31%
-5.72
+68.32%
-18.07
+83.62%
-110.31
Beginning Cash Position
69.33
-7.63%
75.05
-19.40%
93.12
-54.23%
203.43
End Cash Position
129.90
+87.36%
69.33
-7.63%
75.05
-19.40%
93.12
Free Cash Flow
45.99
-73.14%
171.23
+54.91%
110.53
-5.05%
116.41
Interest Paid Supplemental Data
0.00
0.00
-100.00%
1.95
-22.66%
2.52
Income Tax Paid Supplemental Data
16.05
-69.86%
53.25
+45.49%
36.60
+125.94%
16.20
Amortization Of Securities
-1.53
-183.87%
1.82
+1594.26%
-0.12
-103.77%
3.23
Common Stock Issuance
37.62
+152.32%
14.91
+125.54%
6.61
-46.79%
12.42
Dividends Received CFI
—
—
0.00
0.00
Issuance Of Capital Stock
37.62
+152.32%
14.91
+125.54%
6.61
-46.79%
12.42
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category